US · Healthcare

Cresco Labs Inc (CRLBF)

Drug Manufacturers - Specialty & Generic

Cresco Labs Inc (CRLBF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CRLBF

P/E ratio

18.00

Cresco Labs Inc (CRLBF) — FAQ

What is CRLBF's P/E ratio?

The price-to-earnings (P/E) ratio for Cresco Labs Inc (CRLBF) is 18.00 (data as of 2026-05-23).

Does Cresco Labs Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cresco Labs Inc (CRLBF). Check the MyAverix Finance app for the latest dividend data.

What sector is Cresco Labs Inc in?

Cresco Labs Inc (CRLBF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CRLBF listed on?

CRLBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)